ER+, HER2- Metastatic Breast Cancer Hypothetical Patient Case: BreastResistance-Sim
Overview
Welcome to the BreastResistance-Sim metastatic breast cancer (MBC) hypothetical patient case simulation. This simulation guides you through an estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2-) MBC hypothetical patient case. Through this hypothetical patient case, you will understand how genetic alterations may impact a patient’s sensitivity to endocrine therapy (ET).
MMAT-00250
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice